Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.296,01
-0,02%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Millennium Pharmaceuticals (MM) (MLNM) Millennium Pharmaceuticals (MM) (MLNM) Notizie

MLNM

Millennium Pharmaceuticals (MM) (MLNM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MLNM
DataOraFonteTitoloSimboloCompagnia
15/05/200821:50Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
14/05/200823:27Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
14/05/200823:08Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Termination of Registration of a Class of Security under Section 12(g) (15-12G)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
14/05/200822:32Edgar (US Regulatory)Millennium Pharmaceuticals Inc-Notification filed by National Security Exchange to report the removal from listing a... (25-NSE)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
14/05/200819:20PR Newswire (US)Takeda Completes Acquisition of MillenniumNASDAQ:MLNM
14/05/200816:02Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
14/05/200815:30Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
14/05/200813:00PR Newswire (US)Takeda Completes Subsequent Offering Period for Shares of Millennium Pharmaceuticals, Inc.NASDAQ:MLNMMillennium Pharmaceuticals (MM)
12/05/200823:06Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
09/05/200808:21PR Newswire (US)Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering PeriodNASDAQ:MLNMMillennium Pharmaceuticals (MM)
06/05/200822:00PR Newswire (US)Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, CardiNASDAQ:MLNMMillennium Pharmaceuticals (MM)
05/05/200823:42PR Newswire (US)Standard & Poor's Announces Changes to U.S. IndicesNASDAQ:MLNMMillennium Pharmaceuticals (MM)
02/05/200820:21Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
29/04/200814:00PR Newswire (US)Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting PeriodNASDAQ:MLNMMillennium Pharmaceuticals (MM)
11/04/200823:08Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Tender offer statement by Third Party (SC TO-T)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
11/04/200822:19PR Newswire (US)Takeda Commences Cash Tender Offer for all Outstanding Shares of MillenniumNASDAQ:MLNM
10/04/200823:13Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
10/04/200821:12Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Written communication relating to an issuer or third party (SC TO-C)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
10/04/200816:26Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Amended Securities Registration (section 12(g)) (8-A12G/A)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
10/04/200808:15PR Newswire (US)Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net SalesNASDAQ:MLNMMillennium Pharmaceuticals (MM)
10/04/200808:06PR Newswire (US)Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 BillionNASDAQ:MLNMMillennium Pharmaceuticals (MM)
07/04/200819:06Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
07/04/200819:02Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
28/03/200821:41Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
17/03/200812:01PR Newswire (US)Millennium Expands IBD Franchise with Addition of New Development CandidateNASDAQ:MLNMMillennium Pharmaceuticals (MM)
13/03/200812:01PR Newswire (US)Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly DNASDAQ:MLNMMillennium Pharmaceuticals (MM)
12/03/200813:01PR Newswire (US)Eleventh Annual Lehman Brothers Global Healthcare Conference to Webcast Millennium PresentationNASDAQ:MLNMMillennium Pharmaceuticals (MM)
10/03/200814:01PR Newswire (US)Cowen & Company 28th Annual Healthcare Conference to Webcast Millennium PresentationNASDAQ:MLNMMillennium Pharmaceuticals (MM)
29/02/200821:37Edgar (US Regulatory)Millennium Pharmaceuticals Inc - Annual Report (10-K)NASDAQ:MLNMMillennium Pharmaceuticals (MM)
28/02/200823:33PR Newswire (US)2008 Susquehanna Healthcare Conference to Webcast Millennium PresentationNASDAQ:MLNMMillennium Pharmaceuticals (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MLNM

La tua Cronologia

BIT
UC3S9T
Unicredit Bank
BIT
UC6M21
Unicredit Bank
LSE
AEY
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network